APO RESEARCH · REPORT
Custom Antibody Services
Custom antibody services include competitively priced packages and purification options for antibody production. Service Providers offer support for different types and steps of antibody production—from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification. They also immunize with recombinant proteins or protein fragments provided by the customers(or expressed and purified in labs using cDNAs from the service providers’ extensive in-house genomics library) to generate antibodies in rabbits, chickens, goats, guinea pigs, mice, or rats.
Product & engineering
Understand the product.
Custom antibody services include competitively priced packages and purification options for antibody production. Service Providers offer support for different types and steps of antibody production—from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification. They also immunize with recombinant proteins or protein fragments provided by the customers(or expressed and purified in labs using cDNAs from the service providers’ extensive in-house genomics library) to generate antibodies in rabbits, chickens, goats, guinea pigs, mice, or rats.
Selected research
Market Analysis & Forecast
Global Custom Antibody Services Market Analysis and Forecast 2026-2032
Market perspective
Custom antibody services include competitively priced packages and purification options for antibody production. Service Providers offer support for different types and steps of antibody production—from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification. They also immunize with recombinant proteins or protein fragments provided by the customers(or expressed and purified in labs using cDNAs from the service providers’ extensive in-house genomics library) to generate antibodies in rabbits, chickens, goats, guinea pigs, mice, or rats.
North America is the largest region of Custom Antibody Services, with a market share about 40%. It was followed by Europe with 30%. ThermoFisher, Bio-Rad and Covance are the top 3 players of industry, and they had more than 50% combined market share.
Report Includes
Read the full market overview
This report presents an overview of global market for Custom Antibody Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Custom Antibody Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Custom Antibody Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Custom Antibody Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Custom Antibody Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Custom Antibody Services revenue, projected growth trends, production technology, application and end-user industry.
Custom Antibody Services Segment by Company
ThermoFisher
GenScript
Abcam
MBS
ROCKLAND
ProSci
Biocompare
Bio-Rad
Covance
Capra Science
Innovagen
LIFE SCIENCE GROUP
Randox
GL Biochem
Abgent
Custom Antibody Services Segment by Type
Monoclonal
Polyclonal
Others
Custom Antibody Services Segment by Application
BioScience Companies
BioScience Research Institutions
Hospitals
Custom Antibody Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Antibody Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Custom Antibody Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Antibody Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Custom Antibody Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Custom Antibody Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Custom Antibody Services revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Monoclonal
- Polyclonal
- Others
Applications
- BioScience Companies
- BioScience Research Institutions
- Hospitals
Companies covered
- ThermoFisher
- GenScript
- Abcam
- MBS
- ROCKLAND
- ProSci
- Biocompare
- Bio-Rad
- Covance
- Capra Science
- Innovagen
- LIFE SCIENCE GROUP
- Randox
- GL Biochem
- Abgent
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Custom Antibody Services Market by Type
- 1.2.1 Global Custom Antibody Services Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Monoclonal
- 1.2.3 Polyclonal
- 1.2.4 Others
- 1.3 Custom Antibody Services Market by Application
- 1.3.1 Global Custom Antibody Services Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 BioScience Companies
- 1.3.3 BioScience Research Institutions
- 1.3.4 Hospitals
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Custom Antibody Services Market Dynamics
- 2.1 Custom Antibody Services Industry Trends
- 2.2 Custom Antibody Services Industry Drivers
- 2.3 Custom Antibody Services Industry Opportunities and Challenges
- 2.4 Custom Antibody Services Industry Restraints
3 Global Growth Perspective
- 3.1 Global Custom Antibody Services Market Perspective (2021-2032)
- 3.2 Global Custom Antibody Services Growth Trends by Region
- 3.2.1 Global Custom Antibody Services Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Custom Antibody Services Market Size by Region (2021-2026)
- 3.2.3 Global Custom Antibody Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Custom Antibody Services Revenue by Players
- 4.1.1 Global Custom Antibody Services Revenue by Players (2021-2026)
- 4.1.2 Global Custom Antibody Services Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Custom Antibody Services Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Custom Antibody Services Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Custom Antibody Services Key Players Headquarters & Area Served
- 4.4 Global Custom Antibody Services Players, Product Type & Application
- 4.5 Global Custom Antibody Services Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Custom Antibody Services Market CR5 and HHI
- 4.6.3 2025 Custom Antibody Services Tier 1, Tier 2, and Tier 3
5 Custom Antibody Services Market Size by Type
- 5.1 Global Custom Antibody Services Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Custom Antibody Services Revenue by Type (2021-2032)
- 5.3 Global Custom Antibody Services Revenue Market Share by Type (2021-2032)
6 Custom Antibody Services Market Size by Application
- 6.1 Global Custom Antibody Services Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Custom Antibody Services Revenue by Application (2021-2032)
- 6.3 Global Custom Antibody Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 ThermoFisher
- 7.1.1 ThermoFisher Company Information
- 7.1.2 ThermoFisher Business Overview
- 7.1.3 ThermoFisher Custom Antibody Services Revenue and Gross Margin (2021-2026)
- 7.1.4 ThermoFisher Custom Antibody Services Product Portfolio
- 7.1.5 ThermoFisher Recent Developments
- 7.2 GenScript
- 7.2.1 GenScript Company Information
- 7.2.2 GenScript Business Overview
- 7.2.3 GenScript Custom Antibody Services Revenue and Gross Margin (2021-2026)
- 7.2.4 GenScript Custom Antibody Services Product Portfolio
- 7.2.5 GenScript Recent Developments
- 7.3 Abcam
- 7.3.1 Abcam Company Information
- 7.3.2 Abcam Business Overview
- 7.3.3 Abcam Custom Antibody Services Revenue and Gross Margin (2021-2026)
- 7.3.4 Abcam Custom Antibody Services Product Portfolio
- 7.3.5 Abcam Recent Developments
- 7.4 MBS
- 7.4.1 MBS Company Information
- 7.4.2 MBS Business Overview
- 7.4.3 MBS Custom Antibody Services Revenue and Gross Margin (2021-2026)
- 7.4.4 MBS Custom Antibody Services Product Portfolio
- 7.4.5 MBS Recent Developments
- 7.5 ROCKLAND
- 7.5.1 ROCKLAND Company Information
- 7.5.2 ROCKLAND Business Overview
- 7.5.3 ROCKLAND Custom Antibody Services Revenue and Gross Margin (2021-2026)
- 7.5.4 ROCKLAND Custom Antibody Services Product Portfolio
- 7.5.5 ROCKLAND Recent Developments
- 7.6 ProSci
- 7.6.1 ProSci Company Information
- 7.6.2 ProSci Business Overview
- 7.6.3 ProSci Custom Antibody Services Revenue and Gross Margin (2021-2026)
- 7.6.4 ProSci Custom Antibody Services Product Portfolio
- 7.6.5 ProSci Recent Developments
- 7.7 Biocompare
- 7.7.1 Biocompare Company Information
- 7.7.2 Biocompare Business Overview
- 7.7.3 Biocompare Custom Antibody Services Revenue and Gross Margin (2021-2026)
- 7.7.4 Biocompare Custom Antibody Services Product Portfolio
- 7.7.5 Biocompare Recent Developments
- 7.8 Bio-Rad
- 7.8.1 Bio-Rad Company Information
- 7.8.2 Bio-Rad Business Overview
- 7.8.3 Bio-Rad Custom Antibody Services Revenue and Gross Margin (2021-2026)
- 7.8.4 Bio-Rad Custom Antibody Services Product Portfolio
- 7.8.5 Bio-Rad Recent Developments
- 7.9 Covance
- 7.9.1 Covance Company Information
- 7.9.2 Covance Business Overview
- 7.9.3 Covance Custom Antibody Services Revenue and Gross Margin (2021-2026)
- 7.9.4 Covance Custom Antibody Services Product Portfolio
- 7.9.5 Covance Recent Developments
- 7.10 Capra Science
- 7.10.1 Capra Science Company Information
- 7.10.2 Capra Science Business Overview
- 7.10.3 Capra Science Custom Antibody Services Revenue and Gross Margin (2021-2026)
- 7.10.4 Capra Science Custom Antibody Services Product Portfolio
- 7.10.5 Capra Science Recent Developments
- 7.11 Innovagen
- 7.11.1 Innovagen Company Information
- 7.11.2 Innovagen Business Overview
- 7.11.3 Innovagen Custom Antibody Services Revenue and Gross Margin (2021-2026)
- 7.11.4 Innovagen Custom Antibody Services Product Portfolio
- 7.11.5 Innovagen Recent Developments
- 7.12 LIFE SCIENCE GROUP
- 7.12.1 LIFE SCIENCE GROUP Company Information
- 7.12.2 LIFE SCIENCE GROUP Business Overview
- 7.12.3 LIFE SCIENCE GROUP Custom Antibody Services Revenue and Gross Margin (2021-2026)
- 7.12.4 LIFE SCIENCE GROUP Custom Antibody Services Product Portfolio
- 7.12.5 LIFE SCIENCE GROUP Recent Developments
- 7.13 Randox
- 7.13.1 Randox Company Information
- 7.13.2 Randox Business Overview
- 7.13.3 Randox Custom Antibody Services Revenue and Gross Margin (2021-2026)
- 7.13.4 Randox Custom Antibody Services Product Portfolio
- 7.13.5 Randox Recent Developments
- 7.14 GL Biochem
- 7.14.1 GL Biochem Company Information
- 7.14.2 GL Biochem Business Overview
- 7.14.3 GL Biochem Custom Antibody Services Revenue and Gross Margin (2021-2026)
- 7.14.4 GL Biochem Custom Antibody Services Product Portfolio
- 7.14.5 GL Biochem Recent Developments
- 7.15 Abgent
- 7.15.1 Abgent Company Information
- 7.15.2 Abgent Business Overview
- 7.15.3 Abgent Custom Antibody Services Revenue and Gross Margin (2021-2026)
- 7.15.4 Abgent Custom Antibody Services Product Portfolio
- 7.15.5 Abgent Recent Developments
8 North America
- 8.1 North America Custom Antibody Services Revenue (2021-2032)
- 8.2 North America Custom Antibody Services Revenue by Type (2021-2032)
- 8.2.1 North America Custom Antibody Services Revenue by Type (2021-2026)
- 8.2.2 North America Custom Antibody Services Revenue by Type (2027-2032)
- 8.3 North America Custom Antibody Services Revenue Share by Type (2021-2032)
- 8.4 North America Custom Antibody Services Revenue by Application (2021-2032)
- 8.4.1 North America Custom Antibody Services Revenue by Application (2021-2026)
- 8.4.2 North America Custom Antibody Services Revenue by Application (2027-2032)
- 8.5 North America Custom Antibody Services Revenue Share by Application (2021-2032)
- 8.6 North America Custom Antibody Services Revenue by Country
- 8.6.1 North America Custom Antibody Services Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Custom Antibody Services Revenue by Country (2021-2026)
- 8.6.3 North America Custom Antibody Services Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Custom Antibody Services Revenue (2021-2032)
- 9.2 Europe Custom Antibody Services Revenue by Type (2021-2032)
- 9.2.1 Europe Custom Antibody Services Revenue by Type (2021-2026)
- 9.2.2 Europe Custom Antibody Services Revenue by Type (2027-2032)
- 9.3 Europe Custom Antibody Services Revenue Share by Type (2021-2032)
- 9.4 Europe Custom Antibody Services Revenue by Application (2021-2032)
- 9.4.1 Europe Custom Antibody Services Revenue by Application (2021-2026)
- 9.4.2 Europe Custom Antibody Services Revenue by Application (2027-2032)
- 9.5 Europe Custom Antibody Services Revenue Share by Application (2021-2032)
- 9.6 Europe Custom Antibody Services Revenue by Country
- 9.6.1 Europe Custom Antibody Services Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Custom Antibody Services Revenue by Country (2021-2026)
- 9.6.3 Europe Custom Antibody Services Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Custom Antibody Services Revenue (2021-2032)
- 10.2 China Custom Antibody Services Revenue by Type (2021-2032)
- 10.2.1 China Custom Antibody Services Revenue by Type (2021-2026)
- 10.2.2 China Custom Antibody Services Revenue by Type (2027-2032)
- 10.3 China Custom Antibody Services Revenue Share by Type (2021-2032)
- 10.4 China Custom Antibody Services Revenue by Application (2021-2032)
- 10.4.1 China Custom Antibody Services Revenue by Application (2021-2026)
- 10.4.2 China Custom Antibody Services Revenue by Application (2027-2032)
- 10.5 China Custom Antibody Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Custom Antibody Services Revenue (2021-2032)
- 11.2 Asia Custom Antibody Services Revenue by Type (2021-2032)
- 11.2.1 Asia Custom Antibody Services Revenue by Type (2021-2026)
- 11.2.2 Asia Custom Antibody Services Revenue by Type (2027-2032)
- 11.3 Asia Custom Antibody Services Revenue Share by Type (2021-2032)
- 11.4 Asia Custom Antibody Services Revenue by Application (2021-2032)
- 11.4.1 Asia Custom Antibody Services Revenue by Application (2021-2026)
- 11.4.2 Asia Custom Antibody Services Revenue by Application (2027-2032)
- 11.5 Asia Custom Antibody Services Revenue Share by Application (2021-2032)
- 11.6 Asia Custom Antibody Services Revenue by Country
- 11.6.1 Asia Custom Antibody Services Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Custom Antibody Services Revenue by Country (2021-2026)
- 11.6.3 Asia Custom Antibody Services Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Custom Antibody Services Revenue (2021-2032)
- 12.2 SAMEA Custom Antibody Services Revenue by Type (2021-2032)
- 12.2.1 SAMEA Custom Antibody Services Revenue by Type (2021-2026)
- 12.2.2 SAMEA Custom Antibody Services Revenue by Type (2027-2032)
- 12.3 SAMEA Custom Antibody Services Revenue Share by Type (2021-2032)
- 12.4 SAMEA Custom Antibody Services Revenue by Application (2021-2032)
- 12.4.1 SAMEA Custom Antibody Services Revenue by Application (2021-2026)
- 12.4.2 SAMEA Custom Antibody Services Revenue by Application (2027-2032)
- 12.5 SAMEA Custom Antibody Services Revenue Share by Application (2021-2032)
- 12.6 SAMEA Custom Antibody Services Revenue by Country
- 12.6.1 SAMEA Custom Antibody Services Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Custom Antibody Services Revenue by Country (2021-2026)
- 12.6.3 SAMEA Custom Antibody Services Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst